不同全身炎症反应指标对接受胸主动脉腔内修复术的B型主动脉夹层患者长期预后的价值
该研究回顾性分析了本中心2013年1月至2019年1月540例B型主动脉夹层患者的病例数据,按随访期间是否发生主动脉相关不良事件(ARAEs)分为两组。多因素分析确定术前全身炎症反应指数(SIRI)和C反应蛋白与白蛋白比值(CAR)为ARAEs的独立危险因素,并构建SIRI-CAR评分。ROC曲线分析显示SIRI-CAR评分对ARAEs的预测价值优于单独使用SIRI或CAR,Kaplan-Meier生存曲线显示高SIRI、高CAR和高SIRI-CAR评分患者随访期间无ARAEs生存率显著较低。
要点
- 术前SIRI和CAR是TBAD患者TEVAR术后长期ARAEs的独立危险因素。
- SIRI-CAR评分对ARAEs的预测价值优于单独使用SIRI或CAR。
- 高SIRI、高CAR和高SIRI-CAR评分患者随访期间无ARAEs生存率显著较低。
核心结论
- 术前SIRI和CAR与接受TEVAR的TBAD患者长期预后相关,具有良好的预后价值。
- 结合两种指标的SIRI-CAR评分能更有效地预测长期ARAEs风险。
研究设计与样本
- 回顾性研究,纳入本中心2013年1月至2019年1月540例B型主动脉夹层患者。
- 根据随访期间是否发生主动脉相关不良事件(ARAEs)分为ARAEs组和非ARAEs组。
- 采用单因素和多因素分析确定独立危险因素,并构建SIRI-CAR评分。
- 采用ROC曲线分析确定SIRI和CAR预测ARAEs的最佳阈值。
- 采用Kaplan-Meier生存曲线和累积风险曲线比较不同组间的生存状态和ARAEs风险。
主要发现
- 随访期间127例患者发生ARAEs。
- 单因素和多因素分析确定术前SIRI和CAR为ARAEs的独立危险因素。
- ROC曲线分析显示SIRI-CAR评分对ARAEs的预测价值优于单独使用SIRI和CAR。
- Kaplan-Meier生存曲线显示高SIRI、高CAR和高SIRI-CAR评分患者随访期间无ARAEs生存率显著较低。
- 累积风险曲线显示不同SIRI-CAR评分患者各类ARAEs风险存在显著差异,且风险随评分升高而增加。
临床怎么用
- 通过识别关键炎症生物学指标,临床医生可以更好地进行风险分层、个体化治疗和术后恢复监测。
- 将这些指标纳入临床实践可能增强早期干预策略、改善患者结局并可能减少并发症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study is to explore the value of different systemic inflammatory response indicators in the long-term prognosis of type B aortic dissection (TBAD) patients undergoing thoracic endovascular aortic repair (TEVAR). METHODS: This study retrospectively reviewed the case data of 540 patients with TBAD at our center from January 2013 to January 2019. Based on the occurrence of aorta-related adverse events (ARAEs) during follow-up, patients were divided into two groups: the ARAEs group and the non-ARAEs group. Univariate and multivariate analyses identified preoperative systemic inflammatory response index (SIRI) and C-reactive protein-to-albumin ratio (CAR) as independent risk factors for ARAEs. The SIRI-CAR score was then developed using these indicators. Receiver operating characteristic (ROC) curve analysis was employed to determine the optimal thresholds for SIRI and CAR in predicting ARAEs, then allowing for the classification of patients into high and low groups. Kaplan-Meier survival curves were used to compare survival status among patients with different SIRI, CAR, and SIRI-CAR score during follow-up, while cumulative hazard curves were used to assess the risk of various types of ARAEs among patients with differing SIRI-CAR scores. RESULTS: In this study, 127 patients experienced ARAEs during follow-up. Univariate and multivariate analyses identified preoperative SIRI and CAR as independent risk factors for ARAEs. ROC curve analysis showed that the SIRI-CAR score provided superior predictive value for ARAEs compared to using SIRI and CAR separately. Kaplan-Meier survival curves revealed significantly lower ARAE-free survival rates in patients with high SIRI, high CAR, and high SIRI-CAR scores during follow-up. Additionally, cumulative hazard curves highlighted significant differences in the risk of various ARAEs among patients with different SIRI-CAR score, with the risk increasing as the score rose. CONCLUSION: Preoperative SIRI and CAR are associated with the long-term prognosis of TBAD patients undergoing TEVAR, demonstrating good prognostic value. Additionally, the SIRI-CAR score, which combines both indicators, can more effectively predict the risk of long-term ARAEs.Clinical ImpactThis study provides valuable insights into the role of systemic inflammatory response indicators in predicting the long-term prognosis of TBAD patients undergoing TEVAR). By identifying key inflammatory biological indicators, clinicians can better stratify risk, personalize treatment, and monitor post-operative recovery more effectively. The incorporation of these indicators into clinical practice could enhance early intervention strategies, improve patient outcomes, and potentially reduce complications. The innovation lies in the focus on inflammatory responses, offering a novel prognostic tool to guide management decisions for these high-risk patients.
引用
- Xie L, Lin X, Xie Y, et al. The Value of Different Systemic Inflammatory Response Indicators in the Long-term Prognosis of Type B Aortic Dissection Patients Undergoing Thoracic Endovascular Aortic Repair. J Endovasc Ther. 2024. PMID: 39704096. doi:10.1177/15266028241305953
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。